A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- BioMarin Pharmaceutical
- Study ID
- NCT06668805
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Noonan Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 3 Years - 11 Years
- Healthy Volunteers
- Not accepted
Interventions
- Vosoritide Injection — DRUGModified recombinant human C-type natriuretic peptide Vosoritide
Study Details
The purpose of this study in children with Noonan syndrome is to evaluate the effect of 3 doses of vosoritide on growth as measured by AGV after 6 months of treatment. The long-term efficacy and safety of vosoritide at the therapeutic dose will be evaluated up to FAH.
Key Dates
- Start date
- Nov 22, 2024
- Status verified
- May 2026
- Primary completion
- Mar 31, 2027
- Completion
- Sep 30, 2041
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Vosoritide Dose 1 - Low DoseDrug: Vosoritide - Dose 1 Injection • Experimental Drug Lyophilized powder for reconstitution
- Experimental: Vosoritide Dose 2 - Medium DoseDrug: Vosoritide - Dose 2 Injection • Experimental Drug Lyophilized powder for reconstitution
- Experimental: Vosoritide Dose 3- High DoseDrug: Vosoritide Dose 3 Injection • Experimental Drug Lyophilized powder for reconstitution
Primary Outcome Measure
Change from baseline in Annualized Growth Velocity (AGV) [ Time Frame: At 6 months ]
Central Contacts
- Trial Specialist1-800-983-4587
- Study Manager1-800-983-4587
Locations (22)
Find similar trials in Los Angeles, CA
By research site
Childrens Hospital Los Angeles· Los Angeles, CAChildren's Hospital of Orange County Main Campus - Orange· Orange, CAChildren's Hospital Colorado· Aurora, CONemours Children's Hospital, Delaware (Alfred I. Dupont Hospital for Children)· Wilmington, DEChildren's National Medical Center· Washington D.C., DCNicklaus Children's Hospital· Miami, FL
Related Studies
- RASopathy BiorepositoryRecruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio
- Palliative Care Needs of Children With Rare Diseases and Their FamiliesEnrolling By Invitation · Children's National Research Institute · Washington D.C., District of Columbia
- Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathiesRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled TrialRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland